Omega Healthcare Investors earnings release, July 29, 2026
PRESS RELEASE – FOR IMMEDIATE RELEASE
OMEGA REPORTS SECOND QUARTER 2026 RESULTS
AND RECENT DEVELOPMENTS
Completed $126 Million in New Investments in Q2 2026
Increased Quarterly Dividend by $0.01 to $0.68 in August
Raises Full Year Adjusted FFO Guidance
HUNT VALLEY, MARYLAND – July 29, 2026 – Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) announced today its results for the quarter ended June 30, 2026.
SECOND QUARTER 2026 AND RECENT HIGHLIGHTS
Nareit Funds From Operations (“Nareit FFO”), AFFO, FAD and NOI are supplemental non-GAAP financial measures the Company believes are useful in evaluating the performance of real estate investment trusts (“REITs”). Reconciliations and further information regarding these non-GAAP measures are provided at the end of this press release.
CEO COMMENTS
Taylor Pickett, Omega’s Chief Executive Officer, stated, “We are pleased to report strong second quarter results, with FAD per share up 6.3% over the same quarter last year. This reflects our continued accretive investment activity, augmented by active portfolio management. As a result, we were again able to increase our AFFO guidance, moving the midpoint up by two cents to $3.24.”
Mr. Pickett continued, “While we were able to allocate capital to a diverse selection of accretive investments in the second and early third quarter, including our first UK care home operating company acquisition, the dollar amount of the investments is not reflective of our pipeline. Although we do not provide specific acquisitions guidance, based on our pipeline today, we would expect a significant increase in the amount of capital we are able to allocate through the remainder of this year and into early 2027.”
Mr. Pickett concluded, “I have been in the industry for 33 years and I have been fortunate enough to lead Omega for the last 25 years. Now, as I prepare to retire, I can safely say that this is the most favorable operating backdrop that I have known in my career. Furthermore, with our strong operating partners and our exceptional, driven team, I believe Omega is excellently positioned to generate outsized returns for shareholders for many years to come.”
SECOND QUARTER 2026 PORTFOLIO AND RECENT ACTIVITY
Operator Updates:
Ciena – During the second quarter of 2026, the Company transitioned 20 skilled nursing facilities (“SNFs”) included in the Laurels portfolio out of its lease with Ciena Healthcare Management, Inc. (“Ciena”). Of the 20 facilities, 18 were re-leased to Saber, one was re-leased to The Health and Hospital Corporation of Marion County (“HHC”), and one was sold to the Saber PropCo JV. The transaction strengthened the portfolio's credit profile by replacing a lease with trailing 12-month EBITDAR coverage of 0.87x with leases to operators generating EBITDAR coverage above the portfolio mean of 1.65x. In separate transactions completed during the second quarter of 2026 and July 2026, Ciena also sold its eight owned Laurels facilities to the Saber PropCo JV. While these transactions are initially FAD neutral for Omega, they are expected to enhance the operating performance of Ciena's remaining portfolio. Additionally, Omega's 9.9% equity interest in Saber (discussed further below) provides potential upside from future operating improvements at the transitioned facilities.
Genesis – As previously disclosed, Genesis Healthcare, Inc. (“Genesis”) filed for Chapter 11 bankruptcy protection on July 9, 2025. Since filing for bankruptcy, Genesis has made all required contractual rent and interest payments through July 2026. During the second quarter of 2026, Omega received a $16.3 million paydown on the super-priority secured debtor-in-possession (“DIP”) financing, resulting in an outstanding balance of $8.7 million under such financing as of June 30, 2026. In addition, there is $139.8 million of principal outstanding under two secured term loans as of June 30, 2026. In the second quarter of 2026, the Company recognized rental income of $13.3 million for contractual rent payments received from Genesis, and interest income of $5.9 million, consisting of $0.7 million of cash interest and $5.2 million of paid-in-kind interest.
Maplewood – In the second quarter of 2026, Maplewood Senior Living (along with affiliates “Maplewood”) paid $19.6 million in rent (compared to $19.4 million in the first quarter of 2026).
New Investments:
The following table presents investment activity:
$110 Million in Real Estate Acquisitions – In the second quarter of 2026, the Company acquired eight facilities for aggregate consideration of $109.9 million with expected stabilized yields in the low double digits, comprised of:
$16 Million in Real Estate Loans – In the second quarter of 2026, the Company funded $16.4 million in real estate loans, comprised of:
$93 Million in Q3 2026 Real Estate Investment Activity – In the third quarter of 2026, the Company completed $93.2 million of new investments with expected stabilized yields in the low double digits, comprised of:
Unconsolidated Entities Investment Activity – During the second quarter of 2026 and through July 2026, unconsolidated entities in which the Company holds noncontrolling equity interests completed a number of significant real estate and operating transactions, including $124.3 million of net investment activity and the addition of 27 facilities to the Saber platform:
Asset Sales and Loan Repayments:
$563 Million in Asset Sales... (truncated)oceeds ($479.9 million gross), recognizing a gain of $231.7 million. The trailing 12-month EBITDAR coverage of this portfolio was 0.87x as of December 31, 2025.
$172 Million in Loan Repayments – In the second quarter of 2026, the Company received $172.4 million of loan repayments on loans with a weighted average interest rate of 11.4%, including $82.4 million of early repayments on loans with CommuniCare associated with the sales discussed above.
TRIPLE-NET AND MORTGAGE LOAN OPERATOR COVERAGE DATA
The following tables present operator revenue mix, census and coverage data based on information provided by the Company’s operators for the indicated periods. The Company has not independently verified this information and is providing this data for informational purposes only.
FINANCING ACTIVITIES
ATM Program and Dividend Reinvestment and Common Stock Purchase Plan – The following is a summary of the common shares issued through the second quarter of 2026:
Financial statements
Income Statement
Three Months Ended — (in thousands, except per share amounts)
| Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 | ||
|---|---|---|---|---|---|
| Revenues | Rental income | 262,730 | 235,596 | 529,594 | 463,971 |
| Revenues | Real estate tax and ground lease income | 3,756 | 3,606 | 7,509 | 7,409 |
| Revenues | Real estate loans interest income | 35,723 | 32,975 | 68,289 | 66,137 |
| Revenues | Non-real estate loans interest income | 11,033 | 10,022 | 23,622 | 19,976 |
| Revenues | Resident fees and services | 13,987 | 20,644 | ||
| Revenues | Miscellaneous income | 1,017 | 307 | 1,543 | 1,798 |
| Revenues | Total revenues | 328,246 | 282,506 | 651,201 | 559,291 |
| Expenses | Depreciation and amortization | 81,842 | 80,509 | 165,982 | 160,384 |
| Expenses | Interest expense | 48,116 | 52,897 | 97,871 | 105,177 |
| Expenses | Property-level expenses(1) | 16,197 | 3,771 | 25,640 | 7,597 |
| Expenses | General and administrative | 14,384 | 14,084 | 29,379 | 27,405 |
| Expenses | Stock-based compensation expense | 8,742 | 9,234 | 19,334 | 18,444 |
| Expenses | Severance expense | 18,871 | 18,871 | 9,011 | |
| Expenses | Acquisition, merger and transition related costs | 4,660 | 2,010 | 5,774 | 3,474 |
| Expenses | Impairment on real estate properties | 14,215 | 392 | 15,450 | |
| Expenses | (Recovery) provision for credit losses | -5,019 | -4,771 | -8,313 | 321 |
| Expenses | Total expenses | 187,793 | 171,949 | 354,930 | 347,263 |
| Other income (expense) | Other (expense) income – net | -7,215 | 13,751 | -6,139 | 16,798 |
| Other income (expense) | Gain on assets sold – net | 246,519 | 22,886 | 249,543 | 32,961 |
| Other income (expense) | Total other income | 239,304 | 36,637 | 243,404 | 49,759 |
| Other income (expense) | Income before income tax expense and income (loss) from unconsolidated entities | 379,757 | 147,194 | 539,675 | 261,787 |
| Other income (expense) | Income tax expense | -4,618 | -4,528 | -9,724 | -8,139 |
| Other income (expense) | Income (loss) from unconsolidated entities | 4,529 | -2,187 | 8,293 | -1,109 |
| Other income (expense) | Net income | 379,668 | 140,479 | 538,244 | 252,539 |
| Other income (expense) | Net income attributable to noncontrolling interest | -16,845 | -3,880 | -24,372 | -6,908 |
| Other income (expense) | Net income available to common stockholders | 362,823 | 136,599 | 513,872 | 245,631 |
| Basic: | Net income available to common stockholders | 1.21 | 0.46 | 1.68 | 0.8 |
| Diluted: | Net income available to common stockholders | 1.19 | 0.46 | 1.66 | 0.79 |
| Diluted: | Dividends declared per common share | 0.67 | 0.67 | 1.34 | 1.34 |
Income Statement
Three Months Ended — (in thousands, except per share amounts)
| Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 | ||
|---|---|---|---|---|---|
| Net income (1) | 379,668 | 140,479 | 538,244 | 252,539 | |
| Deduct gain from real estate dispositions | -246,519 | -22,886 | -249,543 | -32,961 | |
| Sub-total | 133,149 | 117,593 | 288,701 | 219,578 | |
| Elimination of non-cash items included in net income: | Depreciation and amortization | 81,842 | 80,509 | 165,982 | 160,384 |
| Elimination of non-cash items included in net income: | Depreciation – unconsolidated entities | 8,972 | 1,156 | 18,384 | 1,839 |
| Elimination of non-cash items included in net income: | Impairment on real estate properties | 14,215 | 392 | 15,450 | |
| Elimination of non-cash items included in net income: | Nareit funds from operations (“Nareit FFO”) | 223,963 | 213,473 | 473,459 | 397,251 |
| Elimination of non-cash items included in net income: | Weighted-average common shares outstanding, basic | 298,848 | 291,188 | 297,952 | 287,101 |
| Elimination of non-cash items included in net income: | Restricted stock and PRSUs | 3,414 | 3,495 | 3,214 | 3,599 |
| Elimination of non-cash items included in net income: | Omega OP Units | 13,988 | 8,563 | 14,524 | 8,387 |
| Elimination of non-cash items included in net income: | Weighted-average common shares outstanding, diluted | 316,250 | 303,246 | 315,690 | 299,087 |
| Elimination of non-cash items included in net income: | Nareit funds from operations available per share | 0.71 | 0.7 | 1.5 | 1.33 |
| Adjustments to calculate adjusted funds from operations | Nareit FFO | 223,963 | 213,473 | 473,459 | 397,251 |
| Add back (deduct): | Severance expense (3) | 18,871 | 18,871 | 9,011 | |
| Add back (deduct): | Stock-based compensation expense | 8,742 | 9,234 | 19,334 | 18,444 |
| Add back (deduct): | Straight-line rent and other write-offs (2) | 7,385 | 17,537 | 9,762 | 27,537 |
| Add back (deduct): | Acquisition, merger and transition related costs | 4,660 | 2,010 | 5,774 | 3,474 |
| Add back (deduct): | Other normalizing items – net (4) | 516 | -6,599 | -2,339 | -6,244 |
| Add back (deduct): | Non-cash (recovery) provision for credit losses | -2,780 | -3,431 | -3,831 | 4,148 |
| Add back (deduct): | Adjusted funds from operations (“AFFO”) (1)(5) | 261,357 | 232,224 | 521,030 | 453,621 |
| Adjustments to calculate funds available for distribution | Non-cash expense (6) | 1,328 | 2,750 | 2,626 | 5,937 |
| Adjustments to calculate funds available for distribution | Capitalized interest | -144 | -80 | -280 | -831 |
| Adjustments to calculate funds available for distribution | Non-cash revenue | -14,962 | -11,638 | -29,045 | -24,660 |
| Adjustments to calculate funds available for distribution | Funds available for distribution (“FAD”) (1)(5) | 247,579 | 223,256 | 494,331 | 434,067 |
Income Statement
Three Months Ended June 30, — (in thousands)
| Three Months Ended June 30, – 2026 | Three Months Ended June 30, – 2025 | Six Months Ended June 30, – 2026 | Six Months Ended June 30, – 2025 | |
|---|---|---|---|---|
| Net income | 379,668 | 140,479 | 538,244 | 252,539 |
| Depreciation and amortization | 81,842 | 80,509 | 165,982 | 160,384 |
| Interest expense | 48,116 | 52,897 | 97,871 | 105,177 |
| General and administrative | 41,997 | 23,318 | 67,584 | 54,860 |
| Acquisition, merger and transition related costs | 4,660 | 2,010 | 5,774 | 3,474 |
Balance Sheet
December 31, — (in thousands, except per share amounts)
| June 30, – 2026 – (Unaudited) | December 31, – 2025 | ||
|---|---|---|---|
| Real estate assets | Buildings and improvements | 7,731,936 | 7,901,652 |
| Real estate assets | Land | 1,177,340 | 1,179,463 |
| Real estate assets | Furniture and equipment | 534,282 | 539,775 |
| Real estate assets | Construction in progress | 16,789 | 12,492 |
| Real estate assets | Total real estate assets | 9,460,347 | 9,633,382 |
| Real estate assets | Less accumulated depreciation | -2,991,978 | -2,930,611 |
| Real estate assets | Real estate assets – net | 6,468,369 | 6,702,771 |
| Real estate assets | Real estate loans receivable – net | 1,366,744 | 1,380,949 |
| Real estate assets | Investments in unconsolidated entities | 501,217 | 414,127 |
| Real estate assets | Assets held for sale | 4,000 | |
| Real estate assets | Total real estate investments | 8,336,330 | 8,501,847 |
| Real estate assets | Non-real estate loans receivable – net | 270,166 | 330,322 |
| Real estate assets | Total investments | 8,606,496 | 8,832,169 |
| Real estate assets | Cash and cash equivalents | 39,036 | 27,024 |
| Real estate assets | Restricted cash | 145,173 | 27,539 |
| Real estate assets | Contractual and other receivables – net | 276,092 | 280,774 |
| Real estate assets | Goodwill | 644,441 | 644,626 |
| Real estate assets | Other assets | 303,523 | 236,927 |
| Real estate assets | Total assets | 10,014,761 | 10,049,059 |
| LIABILITIES AND EQUITY | Revolving credit facility | 6,000 | 242,000 |
| LIABILITIES AND EQUITY | Senior notes and other unsecured borrowings – net | 4,018,608 | 4,014,011 |
| LIABILITIES AND EQUITY | Accrued expenses and other liabilities | 347,860 | 352,549 |
| LIABILITIES AND EQUITY | Total liabilities | 4,372,468 | 4,608,560 |
| LIABILITIES AND EQUITY | Common stock $0.10 par value authorized – 700,000 shares, issued and outstanding – 299,111 shares as of June 30, 2026 and 295,539 shares as of December 31, 2025 | 29,911 | 29,553 |
| LIABILITIES AND EQUITY | Additional paid-in capital | 8,807,559 | 8,693,033 |
| LIABILITIES AND EQUITY | Cumulative net earnings | 5,190,964 | 4,677,092 |
| LIABILITIES AND EQUITY | Cumulative dividends paid | -8,696,011 | -8,297,416 |
| LIABILITIES AND EQUITY | Accumulated other comprehensive income | 58,110 | 79,037 |
| LIABILITIES AND EQUITY | Total stockholders’ equity | 5,390,533 | 5,181,299 |
| LIABILITIES AND EQUITY | Noncontrolling interest | 251,760 | 259,200 |
| LIABILITIES AND EQUITY | Total equity | 5,642,293 | 5,440,499 |
| LIABILITIES AND EQUITY | Total liabilities and equity | 10,014,761 | 10,049,059 |